Orion Oyj (BIT:1ORNBV)
Italy
· Delayed Price · Currency is EUR 60.35
-1.10 (-1.79%)
At close: Dec 3, 2025
Revenue Breakdown
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Sale of Goods Revenue | 1.24B | 1.14B |
Log In |
Log In |
Log In | Upgrade
|
| Royalty Income Revenue | 388.10M | 271.00M |
Log In |
Log In |
Log In | Upgrade
|
| Milestone Payments Revenue | 2.60M | 133.80M |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Innovative Medicines Revenue | 573.00M | 525.20M |
Log In |
Log In |
Log In | Upgrade
|
| Branded Products Revenue | 305.70M | 287.50M |
Log In |
Log In |
Log In | Upgrade
|
| Generics and Consumer Health Revenue | 544.90M | 528.40M |
Log In |
Log In |
Log In | Upgrade
|
| Animal Health Revenue | 140.50M | 128.20M |
Log In |
Log In |
Log In | Upgrade
|
| Fermion Revenue | 64.30M | 72.30M |
Log In |
Log In |
Log In | Upgrade
|
| Translation Differences and Other Operations Revenue | 300.00K | 800.00K |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Finland Revenue | 362.00M | 347.40M |
Log In |
Log In |
Log In | Upgrade
|
| Scandinavia Revenue | 180.50M | 163.10M |
Log In |
Log In |
Log In | Upgrade
|
| Other Europe Revenue | 463.70M | 431.30M |
Log In |
Log In |
Log In | Upgrade
|
| North America Revenue | 341.90M | 368.70M |
Log In |
Log In |
Log In | Upgrade
|
| Other Markets Revenue | 280.40M | 231.90M |
Log In |
Log In |
Log In | Upgrade
|
Key Performance Indicators
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2019 |
| Human Pharmaceuticals (Hospital and Pharmacy Channel) Reported Market Share | - |
Log In |
Log In |
Log In | Upgrade
|
| Prescription Drugs (Pharmacy Channel) Reported Market Share | - |
Log In |
Log In |
Log In | Upgrade
|
| Reference Priced Prescription Drugs (Pharmacy Channel) Reported Market Share | - |
Log In |
Log In |
Log In | Upgrade
|
| Self-Care Products (Pharmacy Channel) Reported Market Share | - |
Log In |
Log In |
Log In | Upgrade
|